July 2018 Cancer Epidemiology Matters E-News

Cancer Epidemiology Matters E-News

July 2018

Calling Investigators with Active NCI Grants - New Administrative Supplement Opportunities for Cancer Control Research

Investigators with current NCI grant awards are invited to submit administrative supplement applications for cancer control research in three priority areas – pediatric cancer control, integrative data analysis, and cancer disparities research. The proposed project and budget periods must be within the existing award. Requests for no-cost extensions on the parent grant to accommodate a supplement will not be permitted. Investigators are encouraged to contact the NCI Program Director on their parent grant for questions.

Pediatric Cancer Control Across the Lifespan

In an effort to enhance pediatric cancer control research, NCI is interested in supporting administrative supplements that will increase the understanding of the parent grant by exploring the effects of childhood cancer and its treatment on healthy development among survivors. Additionally, the proposed research will enhance existing cancer control data of pediatric and adolescent and young adult cancer patients, survivors, and their caregivers, as well as adult survivors of pediatric cancers.

To view examples of potential activities of interest to NCI, along with more details about the application process, see NIH Guide Notice NOT-CA-18-088. Applications are due August 17, 2018.

Integrative Data Analysis in Cancer Control and Population Sciences

Integrative data analysis (IDA) methods can be used to study cancer control and behavioral risk factors for cancer, including tobacco and alcohol use, diet and physical activity, environmental exposures, sleep, and adherence to medical screening and vaccine updates. IDA can merge multiple iterations of survey, cohort, or experimental data, or linking data.

NCI is seeking administrative supplement applications that integrate or link multiple existing datasets to answer research questions that cannot be addressed with a single dataset. The NIH Guide Notice, NOT-CA-18-087, offers examples of potential data integration efforts of interest to NCI, along with more details about the application process. Applications are due August 17, 2018.

Cancer Disparity Collaborative Research

The purpose of this supplement is to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental, and population-based research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden, and/or response to treatment in racial/ethnic minorities and/or underserved population groups.

Importantly, the supplement request is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component. To view examples of research areas related to the goals of this opportunity, see the NIH Guide Notice, PA-18-842. Applications are due September 10, 2018.

These priority areas align with recent remarks given by NCI’s Director, Dr. Ned Sharpless, at national conferences (The Power and Promise of Cancer Research at ASCO in June and NCI and the Cancer Community: Focusing on Patients Through Innovative ResearchExternal Web Site Policy at AACR in April).




Are You Looking for Biospecimens for Your Research Project?

Biospecimens are valuable resources in population-based studies and are vital to increasing our understanding of disease etiology, discovering biomarkers for early detection of disease, and much more.

The Epidemiology and Genomics Research Program (EGRP) in NCI’s Division of Cancer Control and Population Sciences (DCCPS) is interested in fostering collaborations among investigators to maximize the use of these critical resources.

EGRP, NCI, and NIH have established a number of websites that may help facilitate scientific collaborations and biospecimen-sharing, including:

Policies and best practices for biospecimen research are also available, such as those provided by the Biorepositories and Biospecimen Research Branch in NCI’s Division of Cancer Treatment and Diagnosis, to aid investigators planning biospecimen collection in new studies. EGRP's biospecimen resources webpage provides links to examples of biospecimen-sharing policies and request forms from NCI-funded population-based studies. The CEDCD also includes links to information about biospecimen policies specific to each cohort in the database.

For questions about biospecimens related to cancer epidemiology research, contact Danielle Carrick, Ph.D., M.H.S., EGRP's Biospecimens Coordinator and a Program Director in the Genomic Epidemiology Branch.

Funding Opportunities

  • Administrative Supplements for Integrative Data Analysis to extend Research in Cancer Control and Population Sciences (Admin Supp - Clinical Trial Optional)
  • Administrative Supplements for NCI Grant and Cooperative Agreement Awards to Support Pediatric Cancer Control Research Across the Lifespan (Admin Supp - Clinical Trial Optional)
  • Administrative Supplements to Support Cancer Disparity Collaborative Research (Admin Supp - Clinical Trial Optional)
  • Diet and Physical Activity Assessment Methodology (R01, R21 - Clinical Trial Not Allowed)
  • Investigator Initiated Research in Computational Genomics and Data Science (R21, R01 - Clinical Trial Not Allowed)*
  • Modular R01s in Cancer Control and Population Sciences (R01 - Clinical Trial Optional)

Grantsmanship Notices

  • Investigators planning to submit cancer epidemiology grant applications to NCI in which subtotal direct costs in any one year ≥$500,000 must seek approval in form of an Awaiting Receipt of Application (ARA) at least 8 weeks prior to submission to NCI or the NIH Center for Scientific Review. Learn about the process and required materials.

Training

Relevant NIH and NCI Blog Posts

Return to Top